article thumbnail

Amgen Backs Therapeutic Antibody Firm

socalTECH

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. Other investors in the round were ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, and Zenyaku Kogyo. READ MORE>>.

article thumbnail

Ceres Raises $20M

socalTECH

Thousand Oaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Ceres has previously raised funds from Warburg Pincus, Soros Private Equity, QuestMark Partners, Oxford BioScience, Oppenheimer, Monsanto, KBC, H&Q, and GIMV.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Activist Investor Third Point Urges Amgen Split

socalTECH

Thousand Oaks-based biotech giant Amgen is a target of activist investor group Third Point , urging the company yesterday to split the company in two. amgen third point activist investors merger acquisition split private equity thirdpoint' READ MORE>>.

article thumbnail

ImmunGene Raises $9M

socalTECH

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group. The startup is led by Sanjay D.

article thumbnail

Ceres, Novozymes In Biofuels Collaboration

socalTECH

Thousand Oaks-based Ceres , a developer of biofuel crop technology, and Novozymes , a developer of enzymes, said today that the two have entered into a research collaboration around cellulosic biofuel production. Ceres is working on both crops to optimize the amount of sugar which can be used to produce biofuel. READ MORE>>.

article thumbnail

Internet Brands Brisco: Deal Will Allow More Focus On Long Term Growth

socalTECH

Los Angeles-based Internet Brands , which operates a suite of online, advertising driven websites across a wide range of verticals, said Monday that it would go private in a $640M, private equity deal, bucking the trend of Southern California companies filing to get to the public markets. Internet Brands had gone public just three years ago.

article thumbnail

Amgen Names Warburg Pincus Exec to Board

socalTECH

Thousand Oaks-based Amgen announced on Thursday that it has added Fred Hassan, Partner and Managing Director at private equity investor Warburg Pincus, to its board. Hassan also was Chairman of the Board and CEO of Schering-Plough Corporation, and had served at Pharmacia Corporation, Ubjohn, Wyeth, and Sandoz Pharmaceuticals.